Liver Cancer Centers of America
2
Liver Cancer Centers of America ("LCCA") provides advanced liver patients with a vast array of uniquely novel yet effective protocols for treating hepatocellular cancer (“HCC�) or metastatic liver cancer (regardless of stage) generally not available within the United States or Canada!
3
LCCA's flagship is CoNexus, a "tumorbusting" cancer therapy designed to destroy (debulk, shrink, reduce, or neutralize) primary or secondary (HCC or Metastatic tumors), often considered "inoperable" by most comprehensive cancer centers.
4
CoNexus is a composition of several government approved oxidants and non-toxic antigen enhancers injected directly into liver tumor(s) under precision CT guidance.
5
Treatments are typically administered once a week for three or four consecutive weeks; take less than 45 minutes per treatment; minimally invasive; and generally cause few, if any sideeffects.
6
CoNexus is designed to serve three vitally important functions: I am Jayden Smith I am here because I love to give presentations. You can find me at @username
7
Destroy late stage or inoperable tumors without surgery, radiation, or chemotherapy, and without causing collateral damage to surrounding tissue - even when tumor is classified inoperable by many well-intended Comprehensive Cancer Centers.
Hinder the spreading of cancer cells (metastasis) by administering systemic autologous tumor antigens designed specifically to enhance cancer cell death (apoptosis).
8
�
Response by administering a systemic dendritic cancer vaccine designed specifically to better identify evasive cancer cells and help destroy, hamper or even reverse progressive tumor growth. 9
�
10
Circulation
11
Circulation
12
Effectiven ess
13
14
Side Effects and Cycles
15
16
THANK Any questions? S! You can find me at
https://livercancercentersofamerica.com /